Skip to content

Study on Prediction of Left Ventricular Remodeling Using ST2

Prediction of ST2 for impRovement of Left ventricUlar Systolic funcTion After Percutaneous Coronary Intervention in Patients With acutE Coronary synDrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03841214
Acronym
TRUSTED
Enrollment
114
Registered
2019-02-15
Start date
2019-02-25
Completion date
2021-06-30
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Brief summary

Patients who underwent percutaneous coronary intervention after diagnosis of acute coronary syndrome should be enrolled in the study and follow - up.

Detailed description

Obtain written consent for patients who meet all of the selection criteria and who do not meet the exclusion criteria. ACS(Acute Coronary Syndrome) patients with LV systolic dysfunction(LVEF\<50%) on TTE test who underwent successful PCI. At that time, patient proceed with the Baseline blood test(ST2) in hospital. And then, Medical therapy for 3 months later patient proceed with the Follow-up blood test(ST2) and TTE in OPD.

Interventions

None listed

Sponsors

Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects aged 19 or older * Patients with acute coronary syndrome who underwent successful percutaneous coronary intervention * Patients with left ventricular ejection fraction less than 50% on transthoracic echocardiography * Patients who voluntarily agreed to participate in the study

Exclusion criteria

* Failure to obtain TIMI 3 flow after procedure * If the remaining life span is less than one year * Women who are breastfeeding or plan to become pregnant or are planning to become pregnant during the study period

Design outcomes

Primary

MeasureTime frameDescription
ST2 and LV end-diastolic volume index3 monthsthe correlation between changes of ST2 and LV end-diastolic volume index

Secondary

MeasureTime frameDescription
ST2 and LV ejection fraction3 monthsthe correlation between changes of ST2 and LV ejection fraction
ST2 and E over e' ratio3 monthsthe correlation between changes of ST2 and E over e' ratio
ST2 and LV wall motion score3 monthsthe correlation between changes of ST2 and LV wall motion score

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026